CV benefit of daily statin therapy in the HOPE-3 trial
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
John Kastelein, MD, PhD
Prof. Alberto Zambon MD, PhD, FAHA
Prof. Kausik Ray, MBChB, MD, MPhil
Azfar Zaman, MD
Stephen Nicholls, FRACP, FACC, FESC, FAHA
- MinuteCE®
Understanding the role of triglycerides in the assessment of residual risk
0.50 program creditsProf. Alberto Zambon MD, PhD, FAHA